CALC

1.2607.69%
AR

A. Rachel Leheny

CEO & Director

Dr. A. Rachel Leheny, Ph.D., is Chief Executive Officer and Director of CalciMedica Subsidiary, Inc. She is Director of Graybug Vision, Inc. from February 5, 2023. She serves as Chief Executive Officer and Director of CalciMedica, Inc., since September 2019. She is a Founder and serves as its Managing Partner and Managing Director of Valence Life Sciences. Dr. Leheny has experience in the life sciences industry. Prior to Valence Advantage, Dr. Leheny co-founded Caxton Advantage in 2004. From April 2000 to May of 2002, she served as the Head of the Biotechnology Research Team and as Senior Vice President at Lehman Brothers. Dr. Leheny headed the Biotechnology Research Team at UBS Warburg. She was Managing Director and Senior Biotechnology Analyst at Hambrecht & Quist. Dr. Leheny serves as Director of the Clearity Foundation. Dr. Leheny served as a Director of Anthera Pharmaceuticals. She was a Board Observer of Corthera. Dr. Leheny was named a Wall Street Journal research All-Star for stock picking in 1996, 1998, and 2002. Dr. Leheny did post-doctoral work at the University of California, Berkeley where she was an NIH fellow and a lecturer, and obtained a Ph.D. in chemistry from Columbia University and an A.B. in Chemistry with honors from Harvard College.

公司职务